| Dr William Kohlberg, MD | |
|
501 Iron Bridge Rd Ste 5, Freehold, NJ 07728-5305 | |
| (732) 780-7603 | |
| (732) 308-3323 |
| Full Name | Dr William Kohlberg |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 501 Iron Bridge Rd Ste 5, Freehold, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063523892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MA38764 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Kohlberg, MD 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728-5305 Ph: (732) 780-7603 | Dr William Kohlberg, MD 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728-5305 Ph: (732) 780-7603 |
News Archive
Weekday delivery is no better than night or weekend delivery for infants with birth defects, according to a new study presented today at The Pregnancy Meeting, the Society for Maternal-Fetal Medicine's annual conference. The finding is good news for all parties - moms, babies and healthcare teams - and suggests that this high-risk population of women should deliver when their bodies are ready to deliver, regardless of the day or time.
Genentech, a member of the Roche Group, today announced positive results from Stage 1 of CLL11, a Phase III randomized study to investigate the efficacy and safety profile of the investigational medicine obinutuzumab (GA101) plus chlorambucil chemotherapy compared with chlorambucil alone in people with previously untreated chronic lymphocytic leukemia (CLL).
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced commencement of a Phase 2 study of a d-Amphetamine Transdermal System (d-ATS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Currently, there is no approved amphetamine-based transdermal treatment option available for ADHD.
Zebrafish can now be used to study COX deficiencies in humans, a discovery that gives scientists an unprecedented window to view the earliest stages of mitochondrial impairments that lead to potentially fatal metabolic disorders, according to researchers at the University of Oregon.
› Verified 8 days ago
Dr. Troy Sukkarieh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728 Phone: 732-780-7603 Fax: 732-308-3323 | |
Dr. Emad Remond Rizkala, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728 Phone: 732-780-7603 Fax: 732-308-3323 | |
Alexander Kirshenbaum, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728 Phone: 732-972-9000 Fax: 732-972-0966 | |
Dr. Matthew J Pagano, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728 Phone: 732-780-7603 Fax: 732-308-3323 | |
Dr. Doh Yoon Cha, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 501 Iron Bridge Rd Ste 5, Freehold, NJ 07728 Phone: 732-780-7603 Fax: 732-308-3323 | |
Dr. Eugene L Desalvo, MD Urology Medicare: Medicare Enrolled Practice Location: 515 Iron Bridge Rd, Freehold, NJ 07728 Phone: 732-780-3434 Fax: 732-780-9334 |